P Lakshmi Narayana

P Lakshmi Narayana (chief executive) discloses dealings in Gland Pharma Limited to SEBI (PIT + SAST). Between 21 May 2021 and 2 February 2026, the trades on record add up to 5 filings.

On the market, this insider has only sold: 4 sales, €266k in total. Outside the open market, there are 1 share grant. So far in 2026, the count stands at no purchases and 1 sale.

Most recently, on 3 February 2026, the filings show an open-market sale worth €14k in Gland Pharma Limited. Filings reach the SEBI (PIT + SAST) feed a median of 1 day after the trade. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.